Combining low-dose CT-based radiomics and metabolomics for early lung cancer screening support

Joanna Zyla, Michal Marczyk, Wojciech Prazuch +9

Due to its predominantly asymptomatic or mildly symptomatic progression, lung cancer is often diagnosed in advanced stages, resulting in poorer survival rates for patients. As with…